0000904454-13-000511.txt : 20130503 0000904454-13-000511.hdr.sgml : 20130503 20130503193313 ACCESSION NUMBER: 0000904454-13-000511 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20130501 FILED AS OF DATE: 20130503 DATE AS OF CHANGE: 20130503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Quart Barry D CENTRAL INDEX KEY: 0001384243 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33221 FILM NUMBER: 13814188 MAIL ADDRESS: STREET 1: C/O INTRABIOTICS PHARMACEUTICALS INC STREET 2: 1009 OAK HILL ROAD, SUITE 201 CITY: LAFAYETTE STATE: CA ZIP: 94549 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AP PHARMA INC /DE/ CENTRAL INDEX KEY: 0000818033 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 942875566 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 123 SAGINAW DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 6503662626 MAIL ADDRESS: STREET 1: 123 SAGINAW DRIVE STREET 2: 123 SAGINAW DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED POLYMER SYSTEMS INC /DE/ DATE OF NAME CHANGE: 19920703 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2013-05-01 0000818033 AP PHARMA INC /DE/ APPA 0001384243 Quart Barry D 123 SAGINAW DRIVE REDWOOD CITY CA 94063 1 1 0 0 Chief Executive Officer Stock Option (right to buy) .36 2013-05-01 4 A 0 22500000 0 A 2023-05-01 Common Stock 22500000 22500000 D Options will vest and become exercisable (a) with respect to 2,812,500 shares on the first anniversary of the date of grant and then with respect to 234,375 shares monthly thereafter over the next three years, and (b) with respect to 11,250,000 shares following the achievement of certain performance goals. /s/ Barry D. Quart 2013-05-02 EX-24 2 quart_050113-poa.htm QUART 5-1-13 POWER OF ATTORNEY Unassociated Document

POWER OF ATTORNEY
 
I hereby constitute and appoint each of Stephen Davis and Ryan Murr as my true and lawful attorney-in-fact to:
 
 
(1)
execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director of AP Pharma, Inc/DE (the “Company”), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the “Act”), and the rules thereunder;

 
(2)
do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5 and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

 
(3)
take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

The undersigned hereby grants to each of the attorneys-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all the acts such attorney-in-fact shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.  The undersigned acknowledges that each of the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, is not assuming any of the undersigned’s responsibilities to comply with Section 16 of the Act.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to each of the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as
of the date set forth below.



 
By:
 
/s/ Barry D. Quart
 
 
Print Name:
 
Barry D. Quart
     
 
Date:
5/2/2013